Overall Technical outlook

Price Summary

2025-12-11, saw MANKIND's stock open at 2148.9, hit a peak of 2177.1, fall to a low of 2130.0, and close higher 0.83% at 2166.8, with 143464 shares changing hands.
In the 52-week period, the stock's peak price is 2998.4, and the lowest price recorded is 2148.9.
17 analysts forecast that the price of MANKIND will range from 2150.0 to 3260.0, with an average expected price near 2683.1765.

Technicals


Aroon: The continuation of Aroon's bearish trend, with Aroon Down still at the 100 level, indicates strong bearish pressure. However, further analysis with additional indicators is essential to better understand the trend's potential impact on the market.
MANKIND aroon 13a031
Aroon chart for Mankind Pharma Limited


Bol. Bands: The price has recently moved above the lower Bollinger Band after being below it in the previous period. This upward crossover suggests that the market may be rebounding from an oversold condition. The move could signal a weakening of the bearish trend and indicate that a shift toward more positive price action might be underway.
MANKIND bbands 13a031
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR remains bearish, reinforcing a resistance level that could restrict any upward movement. This resistance indicates that the market may remain under bearish control, with limited potential for gains.
MANKIND psar 13a031
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The Stochastic K-line is positioned below the D-line and sits under 20, suggesting a mildly bearish scenario. This setup indicates that the market might face some downside pressure, though the bearish signal is not particularly strong. Investors should consider this as a cautious indicator and monitor for further developments.
MANKIND stoch 13a031
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The 20-50-100 period moving averages suggest a bullish trend, though the weakening slopes of the shorter-term averages raise concerns about a potential reversal. While the overall momentum is still upward, the indications from the faster averages suggest that the trend might be nearing its end, warranting caution.
MANKIND trippleSMA 13a031
Tripple SMA chart for Mankind Pharma Limited


To accurately interpret a company's technical data, it is important to first examine its fundamentals. These include financial performance, management quality, and growth prospects. In addition, understanding the dynamics of the industry in which the company operates—such as competition, market trends, and regulatory factors—provides further insights. This combined analysis helps create a fuller picture, allowing for more precise conclusions to be drawn from the company's technical performance and stock behavior.